Trial Profile
A Single Center, Randomized, Double-Blind, Parallel Placebo-Controlled Study of the Safety and Efficacy of Perioperative Remodulin in Orthotopic Liver Transplant Recipients
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 21 Dec 2023
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Liver dysfunction
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 06 Jul 2013 New trial record